Biochemistry, Genetics and Molecular Biology
Genomics
73%
Pan-cancer
57%
Immunity
48%
T Cell
25%
Immune Checkpoints
22%
Transcriptomics
22%
Whole Genome Sequencing
21%
Oncogene
21%
Cancer Cell
21%
Exome Sequencing
20%
Carcinogenesis
17%
Gene Expression
17%
Exome
15%
Immunocompetent Cell
15%
Transcriptome
15%
DNA Methylation
14%
Epigenetics
14%
Somatic Mutation
13%
Gene Mutation
13%
RNA
12%
RNA Sequence
12%
Reprogramming
12%
Long Non-Coding RNA
12%
CD8
11%
Immune Response
11%
Methylation
11%
Messenger RNA
10%
KRAS
10%
PD-L1
10%
Cancer Genomics
10%
Aneuploidy
10%
MicroRNA
10%
Gene Expression Profiling
10%
SMARCA4
10%
Tumor Progression
9%
Catenin
9%
Promoter Region
9%
Tamsulosin
9%
Genetics
9%
SOX9
9%
RNA Sequencing
8%
Immune Microenvironment
8%
Germ Cell
8%
Tumor Suppressor Protein
7%
Metabolic Pathway
7%
T Cell Receptor
7%
Germline Mutation
7%
Enhancer Region
7%
Long Noncoding RNA
7%
Chromosome Instability
7%
Keyphrases
Whole Genome
62%
Pan-cancer Analysis
58%
Tumor
46%
In Cancer
32%
Human Cancer
31%
Cancer Genome Atlas
29%
Cancer Types
26%
Gastric Adenocarcinoma
23%
Molecular Characterization
18%
Mantle Cell Lymphoma
18%
Melanoma
16%
Pan-cancer
13%
High Risk
13%
T Cells
13%
Immune Checkpoint Blockade
13%
Structural Variants
12%
Yes-associated Protein 1 (YAP1)
12%
Tumor Cells
11%
Immune Checkpoint Inhibitors
10%
Ibrutinib
10%
Lung Adenocarcinoma
10%
Tumor Subtype
10%
Tumor Microenvironment
9%
Whole Genome Sequencing
9%
Whole Exome Sequencing
9%
Neoadjuvant
9%
Genetic Modification
9%
Molecular Features
9%
Peritoneal Metastasis
9%
Gene Expression
9%
LncRNA PVT1
9%
Mutational Processes
9%
Mitochondrial DNA
9%
Spatial Transcriptomics
9%
Programmed Death-ligand 1 (PD-L1)
8%
Driver mutations
8%
Tumor Immune Microenvironment
8%
Peritoneal Carcinomatosis
7%
Myeloma
7%
Aneuploidy
7%
Somatic mutation
7%
Immune Cells
7%
Response Evaluation Criteria in Solid Tumors (RECIST)
7%
Genetic mutation
7%
Targeted Therapy
7%
Immune Checkpoint Therapy
7%
Multiple Myeloma
7%
Mutation Profiling
6%
Genome Analysis
6%
Molecular Heterogeneity
6%
Medicine and Dentistry
Malignant Neoplasm
100%
Neoplasm
73%
Cancer
32%
Stomach Adenocarcinoma
27%
Immunity
24%
Mantle Cell Lymphoma
24%
The Cancer Genome Atlas
20%
Melanoma
18%
T Cell
18%
Cancer Types
16%
Tumor Microenvironment
16%
Cancer Cell
15%
Immunotherapy
15%
Transcriptomics
14%
Immune Checkpoint Blockade
14%
Metastatic Carcinoma
14%
Somatics
13%
Diseases
12%
Ibrutinib
11%
Medicine
11%
Cancer Therapy
10%
Ovarian Cancer
9%
Cell Line
9%
Abdominal Cancer
9%
Peritoneum Metastasis
9%
Pembrolizumab
9%
Myeloma
9%
Immune Response
7%
RNA Sequence
7%
Chimeric Antigen Receptor T-Cell
7%
Somatic Mutation
7%
Molecular Profiling
7%
Targeted Therapy
7%
Disease Exacerbation
7%
Large-Cell Lymphoma
7%
Multiple Myeloma
7%
Tumor Cell
6%
Primary Tumor
6%
Progression Free Survival
6%
Immunocompetent Cell
6%
Cytotoxic T-Cell
6%
Lung Adenocarcinoma
6%
Gene Expression Profiling
6%
Carcinomatous Peritonitis
6%
Androgen Receptor
6%
Adverse Event
6%
Exome Sequencing
6%
Oncology
6%
Germinoma
6%
Pediatrics
6%
